Human lung cancer chemoprevention strategies: Parker B. Francis lecture

Chest

Volumn 125, Issue 5 SUPPL., 2004, Pages 123S-127S

  Omenn, Gilbert S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Arachidonic acid pathways; Beta carotene; Chemoprevention; Lung cancer

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DOXORUBICIN; ISOFLAVONE; ISOTHIOCYANIC ACID; PHYTIC ACID; PHYTOSTEROL; POLYPHENOL; RESVERATROL; RETINOL; SELENIUM; TERPENE;

ARACHIDONIC ACID METABOLISM; CANCER CHEMOTHERAPY; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DIET THERAPY; DRUG EFFICACY; DRUG TARGETING; HUMAN; HYPOTHESIS; INHIBITION KINETICS; LUNG CANCER; PRIORITY JOURNAL; SKIN CANCER; VITAMIN SUPPLEMENTATION;

EID: 2442575765     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.5_suppl.123S     Document Type: Conference Paper

References (31)

1. American Cancer Society. Cancer facts and figures 2003. Atlanta, GA: American Cancer Society, 2003
2. Beer DG, Kardia SLR, Huang C-C, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8:816-824
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70
4. Sporn MB, Dunlop NM, Newton DL, et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs [retinoids]. Fed Proc 1976; 35:1332-1338
5. Peto R, Doll R, Buckley JD, et al. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981; 290: 201-208
6. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66:1193-1308
7. Omenn GS. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health 1998; 19:73-99
8. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-1035
9. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of baseline characteristics and study compliance. J Natl Cancer Inst 1996; 88:1560-1570
10. Omenn GS, Goodman GE, Thornquist M, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer incidence, total mortality, and cardiovascular mortality in smokers and asbestos-exposed workers. N Engl J Med 1996; 334:1150-1155
11. Omenn GS, Goodman GE, Thornquist M, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996; 88:1550-1559
12. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334:1145-1149
13. Van Zandwijk N, Pastorino U. Chemoprevention of lung cancer: soon daily practice? Expert Rev Anticancer Ther 2003; 3:91-98
14. Salgo MG, Cueto R, Winston GW, et al. Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 1999; 26:162-173
15. Liu C, Wang X-D, Bronson RT, et al. Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis 2000; 21: 2245-2253
16. Lee BM, Park K-K. Beneficial and adverse effects of chemopreventive agents. Mutat Res 2003; 523-524:265-278
17. Papadimitrakopoulou VA, Hong WK, Lee JS, et al. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst 1997; 89:257-258
18. Greenwald P. Cancer prevention clinical trials. J Clin Oncol 2002; 20:14s-22s
19. Kelley MJ, McCrory DDC. Prevention of lung cancer: summary of published evidence. Chest 2003; 123:50S-59S
20. Epstein KR. The role of carotenoids on the risk of lung cancer. Semin Oncol 2003; 30:86-93
21. Greenberg ER, Sporn MB. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med 1996; 334:1189-1190
22. Ross PE. Spinach in a pill. Forbes 1996; 4:354-355
23. Kelloff GJ, Boone CW, Steele VE, et al. Mechanistic considerations in chemopreventive drug development. J Cell Biochem Suppl 1994; 20:1-24
24. Wattenberg LW, Wiedmann TS, Estensen RD, et al. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 2000; 21:179-182
25. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 1996; 276:1957-1963
26. Reid ME, Duffield-Lillico AJ, Garland L, et al. Selenium supplementation and lung cancer incidence: an update of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11:1285-1291
27. Zusi FC, Lorenzi MV, Vivat-Hannah V. Selective retinoids and rexinoids in cancer therapy and chemoprevention. Drug Discov Today 2002; 7:1165-1174
28. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003; 24:96-102
29. Steele VE, Hawk ET, Viner JL, et al. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. Mutat Res 2003; 523-524:137-144
30. Willis DB, Colburn NH. Molecular targets for cancer prevention: a meeting review of the Third American Cancer Society-Schilling Research Conference. Cancer Epidemiol Biomarkers Prev 2002; 11:972-978
31. Omenn GS, Motulsky AG. Integration of pharmacogenomics into medical practice. In Rothstein MA, ed. Pharmacogenomics: social, ethical, and clinical dimensions. New York, NY: John Wiley & Sons, 2003, 137-162